A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb–IV non-small cell lung cancer (NSCLC)
- 1 January 1999
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 23 (1) , 31-37
- https://doi.org/10.1016/s0169-5002(98)00091-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1998
- Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.Journal of Clinical Oncology, 1998
- Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE)Cancer Letters, 1997
- Chemotherapy in advanced non-small-cell lung cancer. The experience of Italian Cooperative GroupsAnnals of Oncology, 1995
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Clinical and preclinical activity of 2′,2′- difluorodeoxycytidine (gemcitabine)Cancer Treatment Reviews, 1993
- Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1992
- Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literatureLung Cancer, 1991
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1985